Author

Esther Donado

Observed names: E Donado, E. Donado

Institutions: Hospital Costa del Sol, Boehringer Ingelheim (Spain)

Observed institutions: Brigham and Women's Hospital, Boehringer Ingelheim (Germany), Harvard University, Hospital Costa del Sol, Uriach (Spain), Boehringer Ingelheim (Spain)

OpenAlex ID: A5111736040

Rupatadine in the treatment of chronic idiopathic urticaria: a double‐blind, randomized, placebo‐controlled multicentre study

2007 · A. Gimenez‐Arnau, R. M. Pujol, et al. · Allergy · 106

A 12‐week placebo‐controlled study of rupatadine 10 mg once daily compared with cetirizine 10 mg once daily, in the treatment of persistent allergic rhinitis

2008 · S. Fantin, J. Maspero, et al. · Allergy · 60

Validation of the COPD severity score for use in primary care: the NEREA study

2009 · M. Miravitlles, C. Llor, et al. · European Respiratory Journal · 44

Safety of Rupatadine Administered Over a Period of 1 Year in the Treatment of Persistent Allergic Rhinitis

2009 · Antonio Valero, Fernando de la Torre, et al. · Drug Safety · 39

Pharmacokinetic and safety profile of rupatadine when coadministered with azithromycin at steady-state levels: a randomized, open-label, two-way, crossover, Phase I study

2008 · Anna Solans, Iñaki Izquierdo, et al. · Clinical Therapeutics · 24

Rupatadine does not potentiate the CNS depressant effects of lorazepam: randomized, double‐blind, crossover, repeated dose, placebo‐controlled study

2010 · Consuelo García‐Gea, Maria Rosa Ballester, et al. · British Journal of Clinical Pharmacology · 16

Profile of Patients Diagnosed With Acute Venous Thromboembolism in Routine Clinical Practice: The RE-COVERY DVT/PE™ Study

2020 · Samuel Z. Goldhaber, Walter Ageno, et al. · The American Journal of Medicine · 13

Clopidogrel and metoprolol in myocardial infarction

2006 · Javier Borja, Olga García, et al. · The Lancet · 12

Health-related quality of life in nonvalvular atrial fibrillation patients with controlled or uncontrolled anticoagulation status

2020 · José Felipe Varona, José Miguel Seguí-Ripoll, et al. · Health and Quality of Life Outcomes · 8

Gastrointestinal safety of triflusal solution in healthy volunteers: a proof of concept endoscopic study

2011 · Rosa M. Antonijoan, Ignasi Gich, et al. · European Journal of Clinical Pharmacology · 7

Patients’ perceptions with dabigatran in patients with atrial fibrillation previously treated with vitamin K antagonists

2020 · Vivencio Barrios, Carlos Escobar, et al. · Journal of Comparative Effectiveness Research · 3

Seriousness of adverse events: medical judgment is important

2004 · Javier Borja, Esther Donado, et al. · BMJ · 2

Prs17 Validation of the Copd Severity Score for Use in the Spanish Primary Health Care System, the Nerea Study: Preliminary Results

2006 · M Ferrer, M Miravitlles, et al. · Value in Health · 1

Correction to: Health-related quality of life in nonvalvular atrial fibrillation patients with controlled or uncontrolled anticoagulation status

2021 · the REQUOL Study Group, José Felipe Varona, et al. · Health and Quality of Life Outcomes

Characterization of 6,122 Patients With Acute Venous Thromboembolism in Routine Clinical Practice: Re-covery Dvt/petm Prospective Global Cohort Study

2018 · Samuel Z. Goldhaber, Walter Ageno, et al. · Journal of the American College of Cardiology

Works count: 15

Citation count: 335

H-index: 8

I10-index: 8